TOXUSA LABS LLC NPI 1073985727

NPI Information

  • NPI: 1073985727
  • Provider Name: TOXUSA LABS LLC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • Doing Business As: CONNECTDX LABORATORIES
  • CLIA Number: 15D2102246
  • Address: 236 W EDISON RD
    SUITE 5
    MISHAWAKA, IN
    ZIP 46545
  • Phone: (574) 703-2272

Map and Directions

Get Directions

NPI Details

TOXUSA LABS LLC is a clinical medical laboratory in Mishawaka, IN. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. TOXUSA LABS LLC NPI is 1073985727. The provider is registered as an organization entity type.
The provider Is Doing Business As Connectdx Laboratories.

The provider's business location address is:

236 W EDISON RD
SUITE 5
MISHAWAKA, IN
ZIP 46545-184
Phone: (574) 703-2272
Fax: (574) 343-1505

The provider's authorized official is Eyad Khadr .
The authorized official title is Owner and has the following contact phone number (574) 703-2272.

The CLIA number assigned to this NPI record is 15D2102246 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
  • Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
  • Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
  • Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Magnesium level (HCPCS:83735)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • Folic acid level, serum (HCPCS:82746)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Urine microalbumin (protein) level (HCPCS:82043)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Hemoglobin a1c level (HCPCS:83036)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
  • Testosterone (hormone) level, total (HCPCS:84403)
  • Measurement of total estradiol (hormone) (HCPCS:82670)
  • Dehydroepiandrosterone (dhea-s) hormone level (HCPCS:82627)
  • Vitamin d-3 level (HCPCS:82306)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Gonadotropin, follicle stimulating (reproductive hormone) level (HCPCS:83001)
  • Gonadotropin, luteinizing (reproductive hormone) level (HCPCS:83002)
  • Progesterone (reproductive hormone) level (HCPCS:84144)
  • Sex hormone binding globulin (protein) level (HCPCS:84270)
  • Testosterone (hormone) level, free (HCPCS:84402)
  • Human growth hormone level (HCPCS:83003)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Prolactin (milk producing hormone) level (HCPCS:84146)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
  • Amylase (enzyme) level (HCPCS:82150)
  • Lipase (fat enzyme) level (HCPCS:83690)
  • Thyroid hormone, t3 measurement, total (HCPCS:84480)
  • Rheumatoid factor level (HCPCS:86431)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Homocysteine (amino acid) level (HCPCS:83090)
  • Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
  • C-peptide (protein) level (HCPCS:84681)
  • Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
  • Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
  • Detection of mycoplasma genitalium by dna or rna probe (HCPCS:87563)
  • Insulin measurement, total (HCPCS:83525)
  • Bilirubin level, direct (HCPCS:82248)
  • Bacterial colony count, urine (HCPCS:87086)
  • Blood glucose (sugar) level after receiving dose of glucose (HCPCS:82950)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Blood potassium level (HCPCS:84132)
  • Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)

The enumeration date for this NPI number is 10/21/2015 and was last updated on 10/31/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1291U00000XClinical Medical Laboratory15D2102246INDIANAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.